# Intravenous Thrombolysis With Tenecteplase Plus Thrombectomy Versus Thrombectomy Alone In Patients With A Large Ischemic Stroke: A Multicenter Randomized Controlled Trial (IVT-ALL-IN)

Study · id `cardio:ct-nct07603440` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07603440](<https://clinicaltrials.gov/study/NCT07603440>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07603440

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 486 participants.

## Technical summary

Registry record NCT07603440. Randomized; no masking; primary purpose treatment. Start 2026-06-15 (anticipated); primary completion 2029-07-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 486 participants (planned count; ClinicalTrials.gov record NCT07603440, source copy `cardio:ctgov-nct07603440-2026-05-22`, retrieved 2026-10-26)
- Planned start: 2026-06-15 (anticipated) (ClinicalTrials.gov record NCT07603440, source copy `cardio:ctgov-nct07603440-2026-05-22`, retrieved 2026-10-26)
- Primary completion: 2029-07-01 (anticipated) (ClinicalTrials.gov record NCT07603440, source copy `cardio:ctgov-nct07603440-2026-05-22`, retrieved 2026-10-26)
- Completion: 2029-07-01 (anticipated) (ClinicalTrials.gov record NCT07603440, source copy `cardio:ctgov-nct07603440-2026-05-22`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT07603440, source copy `cardio:ctgov-nct07603440-2026-05-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07603440-2026-05-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Intravenous Thrombolysis With Tenecteplase Plus Thrombectomy Versus Thrombectomy Alone In Patients With A Large Ischemic Stroke: A Multicenter Randomized Controlled Trial (IVT-ALL-IN)
- Acronym: IVT-ALL-IN
- Condition: Stroke
- Intervention (Drug): Intravenous administration
- Intervention (Procedure): MT alone
- Lead sponsor: Assistance Publique - Hôpitaux de Paris
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Assistance Publique - Hôpitaux de Paris (`cardio:org-assistance-publique-hopitaux-de-paris`)

## Provenance

Content hash: 77d450966956169cef066ce698e57dcdcbc1facfdea13c30f273b8cd0b18fcf9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
